Deep coma in a child treated with propranolol for infantile hemangioma

BMC Pediatrics

  ^{1    2    2    2    2    2    2    2} 

[1] 0000 0000 9259 8492, grid.22937.3d, Medical University of Vienna, Vienna, Austria;Pediatric Intensive Care Unit, University Hospital Center “Mother Theresa”, Rruga e Dibres, 376, Tirana, Albania;

关键词: Infantile hemangioma;    propranolol;    adverse effects;   

DOI  :  10.1186/s12887-019-1598-0

来源: publisher

【 摘 要 】

BackgroundPropranolol hydrochloride is the first-line agent recommended for the treatment of infantile hemangiomas (IH). Serious adverse effects of propranolol therapy for hemangiomas are infrequent.Case presentationWe report a case presented in deep hypoglycemic coma during his treatment with propranolol for IH. Through our case report and the review of the literature, we aimed to underline the importance of recognizing adverse effects during propranolol therapy. Although propranolol has a long history of safe and effective use in infants and children, pediatricians should be aware that life-threatening adverse effects can happen during propranolol therapy for IH.ConclusionEarly identification of these adverse effects can be of great importance for patient management and prognosis. It must certainly be noted that not just early identification among doctors, but education for parents is crucial.

【 授权许可】

CC BY